Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
Open Access
- 1 March 2009
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 23 (3) , 337-348
Abstract
Somatostatin (SRIF) binds G protein-coupled SRIF receptor subtypes (SST1, -2, -3, -4, and -5) to regulate cell secretion and proliferation. Hypothalamic SRIF inhibits pituitary growth hormone, thyroid stimulating hormone, and ACTH secretion. We tested SRIF-independent constitutive SST activity in AtT20 mouse pituitary corticotroph cells in which ACTH secretion is highly sensitive to SRIF action. Stable transfectants expressing SST2 or SST5 were sensitized to selective agonist action, and constitutive SST receptor activity was demonstrated by forskolin and pertussis toxin cAMP cell responses. Persistent constitutive SST activity decreased cell ACTH responses to CRH through decreased expression of CRH receptor subtype 1. Decreased dopamine receptor type 1 expression was associated with attenuated dopamine agonist action, whereas responses to isoproterenol were enhanced through increased β2-adrenoreceptor expression. Thus, integrated pituitary cell ACTH regulation is determined both by phasic SRIF action, as well as by tonic constitutive SST activity, independently of SRIF.Keywords
This publication has 49 references indexed in Scilit:
- Somatostatin regulates hepatic growth hormone sensitivity by internalizing growth hormone receptors and by decreasing transcription of growth hormone receptor mRNAsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Pharmacogenomic and Structural Analysis of Constitutive G Protein–Coupled Receptor ActivityAnnual Review of Pharmacology and Toxicology, 2007
- Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cellsMolecular and Cellular Endocrinology, 2007
- Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmissionEuropean Journal of Neuroscience, 2006
- Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discoveryTrends in Pharmacological Sciences, 2006
- Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptorsTrends in Pharmacological Sciences, 2005
- Somatostatin Receptor Type 5 Modulates Somatostatin Receptor Type 2 Regulation of Adrenocorticotropin SecretionJournal of Biological Chemistry, 2005
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Autoregulation of the Human D 1A Dopamine Receptor Gene by cAMPDNA and Cell Biology, 1996
- Patterns of Growth Hormone-Eeleasing Factor and Somatostatin Secretion into the Hypophysial-Portal Circulation of the RatScience, 1985